[1]
S. B. Santoso, P. U. Chabibah, and P. Pribadi, “Hepatotoxicity Risk Profile of Indonesian Due to Polymorphism of NAT2 and CYP2E1 in Isoniazid Metabolism”, UJAS, vol. 1, no. 1, pp. 9–16, Apr. 2021.